GeneDx
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $114,440 | $102,254 | $120,989 | $116,743 |
Gross Profit | 78,238 | 68,211 | 78,923 | 84,527 |
EBITDA | -10,359 | -54,893 | -10,829 | -352 |
EBIT | -17,073 | -61,702 | -17,710 | -6,826 |
Net Income | -17,740 | -63,316 | -17,666 | -7,635 |
Net Change In Cash | 114,440 | 102,254 | 120,989 | 116,743 |
Free Cash Flow | -39,095 | -38,861 | -7,437 | 9,595 |
Cash | 60,317 | 93,924 | 104,997 | 95,968 |
Basic Shares | 29,710 | 29,335 | 26,891 | 28,797 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $427,539 | $305,450 | $202,566 | $234,694 |
Gross Profit | 298,173 | 194,397 | 90,006 | -26,750 |
EBITDA | 6,626 | -27,644 | -136,460 | -398,198 |
EBIT | -18,598 | -49,597 | -170,194 | -457,507 |
Net Income | -21,021 | -52,286 | -175,767 | -548,980 |
Net Change In Cash | 427,539 | 305,450 | 202,566 | 234,694 |
Cost of Revenue | -263,166 | |||
Free Cash Flow | 14,262 | -33,987 | -185,858 | -333,477 |
Cash | 104,997 | 85,212 | 99,681 | 137,403 |
Basic Shares | 26,891 | 26,891 | 24,311 | 10,236 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | $0.01 |
2026-03-31 | -$0.28 |
2025-12-31 | $0.14 |
2025-09-30 | $0.49 |